Print this page    •   Back to Web version of article

HIV Management in Depth: A Series Exploring Key Issues in HIV Care

HIV Management in Depth: A Series Exploring Key Issues in HIV Care
John Steever, M.D.
Featuring John Steever, M.D.
"When you give a diagnosis of HIV positive to a youth, not only are you giving them difficult news, which they may or may not be developmentally equipped to deal with, but they frequently have other variables in their life that make it more difficult."
Aug. 28, 2014
Full Interview
Edward Machtinger, M.D.
Featuring Edward Machtinger, M.D.
When treating an HIV-positive person, itís already a fair amount of work, and sometimes quite the balancing act, just to focus on the numbers: CD4 count, viral load, lipid levels, renal markers, and so on. But for a massive number of people with HIV, how well they are doing can't solely be measured numerically.
Jul. 21, 2014
Full Interview
Mark Harrington
Featuring Mark Harrington recently interviewed longtime activist Mark Harrington, the executive director of Treatment Action Group. Harrington talks about the ramifications of the PARTNER study results, as well as what to expect from HIV treatment and care in the next five years.
Jun. 23, 2014
Full Interview
David Alain Wohl, M.D.
Featuring David Alain Wohl, M.D.
A major study published recently in the Annals of Internal Medicine has reinvigorated discussion about the link between cardiovascular disease and HIV. Not that the debate over the complex interplay between HIV and heart health had been dissipating -- if anything, it's one of the hottest areas of HIV research, dovetailing with issues ranging from inflammation to senescence.
Apr. 27, 2014
Full Interview
David Harrich, Ph.D.
Featuring David Harrich, Ph.D.
Gene therapy is one of several avenues being explored by researchers hunting for a way to beat HIV once and for all. But to many of us, the science being conducted in this area is a black box: We periodically read about study results, be they encouraging or discouraging, without understanding much of the effort behind them.
Mar. 31, 2014
Full Interview
Jeffrey Martin, M.D., M.P.H.
Featuring Jeffrey Martin, M.D., M.P.H.
A flurry of newly presented and published research seeks to peel away the remaining curtains that block a more complete understanding of Kaposi's sarcoma epidemiology and treatment.
Mar. 25, 2014
Full Interview
Jonathan Li, M.D.
Featuring Jonathan Li, M.D.
A highly respected HIV research team in Boston is conducting a study on the effect of single-pill, once-daily antiretroviral therapy on HIV-positive people who, until recently, we didn't think needed to be on treatment at all.
Mar. 11, 2014
Full Interview
Jül Gerrior-Schofield, R.D.
Featuring Jül Gerrior-Schofield, R.D.
Long overshadowed by dramatic advances in antiretroviral therapy and more medicine-oriented approaches to disease management, we frequently underappreciate the potential for dietary and nutritional interventions to improve patient treatment outcomes.
Dec. 12, 2013
Full Interview
Benjamin Young, M.D., Ph.D.
Featuring Benjamin Young, M.D., Ph.D.
Poor antiretroviral adherence is a leading cause of HIV treatment failure and the development of drug resistance. But what is the precise level of adherence that a patient needs to observe in order to ensure treatment success? Should we even aim for a specific number?
Oct. 17, 2013
Full Interview
Michael Saag, M.D.,
Michael Wong, M.D.
Featuring Michael Saag, M.D., and Michael Wong, M.D.
The Affordable Care Act: The name alone is enough to make the eyes of clinicians and patients alike glaze over. Yet the impact of the ACA (colloquially called Obamacare) has the potential to be massive when it comes to access to clinical care for HIV-infected people in the U.S.
Aug. 22, 2013
Full Interview
Douglas Dieterich, M.D.,
Daniel Fierer, M.D.
Featuring Douglas Dieterich, M.D., and Daniel Fierer, M.D.
Within a stunningly brief span of time, our understanding of HIV/hepatitis C coinfection and patient care has undergone a dramatic evolution. Two leading experts bring us up to date.
Jun. 19, 2013
Full Interview
David Alain Wohl, M.D.
Featuring David Alain Wohl, M.D.
Cardiovascular disease is, almost by definition, a major topic of concern for the HIV-positive people we count among our patients and clients -- many of whom are intimately associated with traditional cardiovascular risk factors.
Apr. 25, 2013
Full Interview

Past Interviews
Francine Cournos, M.D., and David Fawcett, Ph.D., LCSW
Mar. 14, 2013
Antonio E. Urbina, M.D.
Sep. 28, 2012
Joel Gallant, M.D., M.P.H., and Paul Sax, M.D.
Jul. 18, 2012
Marshall Glesby, M.D., Ph.D., and Jens Lundgren, M.D.
Dec. 6, 2010
Daniel Berger, M.D.
Nov. 12, 2010
Kimberly Smith, M.D., M.P.H., and Valerie E. Stone, M.D., M.P.H.
Dec. 11, 2009
Eric Daar, M.D., and Trevor Hawkins, M.D.
Nov. 11, 2009

Copyright © 2014 Remedy Health Media, LLC. All rights reserved.

This article was provided by It is a part of the publication HIV Management in Depth. You can find this article online by typing this address into your Web browser:

General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.